GleamWall
中文EN

SKIN SkinHealth Systems Inc.

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1818093 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-4.4%
TTM net income YoY-55.7%
TTM EPS YoY117.5%
Revenue 3-yr CAGR-10.3%
Net income 3-yr CAGR—

Margins

Gross margin67.2%
Operating margin2.4%
Net margin-6.3%
FCF margin7.9%
EBITDA margin3.2%

Returns

ROE-30.1%
ROA-4.1%
ROIC (approx.)7.1%
Asset turnover0.65x

Leverage & solvency

Liabilities / assets85.7%
Debt / equity0.00x
Current ratio2.89x
Interest coverage0.27x

Cash quality & payout

Operating cash flow / net income-1.29x
Accruals ratio-9.4%
Payout ratio—
Capex / revenue0.3%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$300.79M$334.29M
Cost of revenue$104.43M$152.00M
Gross profit$196.36M$182.30M
R&D expense$5.63M$6.30M
SG&A expense$117.95M$125.46M
Operating income-$20.80M-$67.77M
Interest expense$19.33M$10.41M
Pretax income-$5.94M-$29.55M
Income tax$3.58M-$452,000
Net income-$9.52M-$29.10M
EBITDA-$16.95M-$57.83M
EPS (basic)-0.08-0.23
EPS (diluted)-0.16-0.36
Weighted avg. shares (diluted)135.80M142.49M
Balance sheet
Cash & equivalents$232.67M$370.06M
Receivables$21.74M$27.64M
Inventory$48.01M$69.11M
Current assets$309.52M$477.12M
PP&E, net$2.54M$5.98M
Goodwill$126.62M$123.50M
Intangibles$35.76M$47.51M
Total assets$499.80M$685.68M
Current liabilities$186.28M$68.15M
Long-term debt—$552.20M
Total debt—$552.20M
Total liabilities$438.75M$633.88M
Shareholders' equity$61.06M$51.80M
Net debt—$182.13M
Shares outstanding6.38M124.92M
Cash flow statement
Operating cash flow$37.48M$16.13M
Capital expenditure$303,000$756,000
Free cash flow$37.18M$15.38M
Investing cash flow-$5.16M-$6.79M
Financing cash flow-$174.93M-$158.34M
Depreciation & amortization$3.85M$9.94M
Stock-based compensation$14.82M$26.70M
Share buybacks$0$0

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.